from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2892c/PPE45

LFCtreatmentdescriptionclass of inhibitor

0.153

Amikacinug/mL Amikacintranslation

0.808

Cap5-10ug/mL Capreomycintranslation

1.501

Rox10-50 ug/mL Roxithromycintranslation

0.181

SM2-5 ug/mL Streptomycintranslation

0.433

Tet5-10 ug/mL Tetracyclinetranslation

1.007

Rif0.2-5ug/mL Rifampicintranscription

0.443

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.478

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.380

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.192

CPZ10-50 ug/mL Chlorpromazinerespiration

0.999

Clofazimine10-13 ug/mL Clofaziminerespiration

0.709

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.910

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.594

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.000

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.439

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.704

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.024

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.305

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.394

Nigericin50 uM Nigericinrespiration

-0.247

TRC10-150 ug/mL Triclosanrespiration

0.170

TRZ10-25 ug/mL Thioridazinerespiration

2.126

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.597

menadione6-10 ug/mL Menadionerespiration

0.154

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.265

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.152

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.642

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.457

NRP_1Non-replicating persistence stage 1dosRassociated

-0.030

Amp0.2mg/mL AmpicillincellWall

-0.179

Cephalexin20-100 ug/mL CephalexincellWall

0.802

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.248

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.313

EMB10-20 ug/mL EthambutolcellWall

-0.208

Eta12-40 ug/mL EthionamidecellWall

-0.135

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.258

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.274

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.572

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.424

BZA0.12 mg/mL BenzamidearomaticAmides

-1.153

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-1.287

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.129

H2O24 mM hydrogen peroxideDNAdamaging

-0.233

Levo10 ug/mL LevofloxacinDNAdamaging

0.248

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.184

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.111

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.040

UVUV-irradiationDNAdamaging

0.040

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.378

Antimycin12.5-50 ug/mL Antimycin A?

-0.957

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.098

PA_110-50 ug/mL Antitubercular compound PA-1?

0.263

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.344

PA8240.2-2 ug/mL PA-824?

0.116

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.356

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.670

Verapamil50 uM Verapamil?

-1.105

mercaptoethanol2 mM 2-Mercaptoethanol?

0.133

methoxatin10-20 ug/mL Methoxatin?